NERVGEN PHARMA CORP. Interest Expense On Lease Liabilities
NERVGEN PHARMA CORP. (NGEN) reported Interest Expense On Lease Liabilities of CAD 3.69 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpenseOnLeaseLiabilities · last filed 2026-03-31
| Period end | Interest Expense On Lease Liabilities 12 month |
|---|---|
| 2025-12-31 | 3.69K CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 9.34K CAD 40-F · filed 2026-03-31 |